Quarterly Operating Lease, Payments in USD from Q1 2022 to Q2 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary: Dianthus Therapeutics, Inc. /DE/ quarterly/annual Operating Lease, Payments history and growth rate from Q1 2022 to Q2 2023.
Dianthus Therapeutics, Inc. /DE/ Operating Lease, Payments for the quarter ending June 30, 2023 was $0.000, a 100% decline year-over-year.
Dianthus Therapeutics, Inc. /DE/ Operating Lease, Payments for the twelve months ending June 30, 2023 was $19.8M.

Operating Lease, Payments, Trailing 12 Months (USD)

Operating Lease, Payments, Quarterly (USD)

Operating Lease, Payments, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2023	$19.8M	$0	-$1.62M	-100%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-03
Q1 2023	$21.4M	$16.5M	+$14.9M	+932%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$6.57M	$1.68M			Oct 1, 2022	Dec 31, 2022	10-K	2023-03-23
Q3 2022		$1.67M			Jul 1, 2022	Sep 30, 2022	10-Q	2022-11-03
Q2 2022		$1.62M			Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022		$1.6M			Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.